1. Home
  2. INTG vs CMMB Comparison

INTG vs CMMB Comparison

Compare INTG & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

HOLD

Current Price

$36.90

Market Cap

59.3M

Sector

Real Estate

ML Signal

HOLD

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$1.60

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTG
CMMB
Founded
1965
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.3M
13.2M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
INTG
CMMB
Price
$36.90
$1.60
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
4.6K
45.5K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
101.67
EPS
0.46
0.04
Revenue
$74,753,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$78.71
$39.75
Revenue Growth
4.43
N/A
52 Week Low
$10.37
$0.87
52 Week High
$42.50
$3.86

Technical Indicators

Market Signals
Indicator
INTG
CMMB
Relative Strength Index (RSI) 58.73 43.47
Support Level $25.16 $1.48
Resistance Level $41.75 $1.64
Average True Range (ATR) 1.87 0.18
MACD -0.19 -0.03
Stochastic Oscillator 80.41 15.91

Price Performance

Historical Comparison
INTG
CMMB

About INTG Intergroup Corporation (The)

The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.

Share on Social Networks: